Login / Signup
Natalie E Bennett
ORCID
Publication Activity (10 Years)
Years Active: 2023-2023
Publications (10 Years): 3
2025
2016
Top Topics
2025
2016
Patient Safety
2025
2016
Mesenchymal Stem Cells
2025
2016
Iron Oxide
2025
2016
Adverse Drug
Top Venues
Cancer research communications
Cancers
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
David C Florian
,
Natalie E Bennett
,
Mateusz Odziomek
,
Jessalyn J Baljon
,
Mohamed Wehbe
,
Alyssa R Merkel
,
Melissa A Fischer
,
Michael R Savona
,
Julie A Rhoades
,
Scott A Guelcher
,
John Tanner Wilson
Nanoparticle STING Agonist Reprograms the Bone Marrow to an Antitumor Phenotype and Protects Against Bone Destruction.
Cancer research communications
3 (2) (2023)
Erik P Beadle
,
Natalie E Bennett
,
Julie A Rhoades
Bioinformatics Screen Reveals Gli-Mediated Hedgehog Signaling as an Associated Pathway to Poor Immune Infiltration of Dedifferentiated Liposarcoma.
Cancers
15 (13) (2023)
David C Florian
,
Natalie E Bennett
,
Mateusz Odziomek
,
Jessalyn J Baljon
,
Mohamed Wehbe
,
Alyssa R Merkel
,
Melissa A Fischer
,
Michael R Savona
,
Julie A Rhoades
,
Scott A Guelcher
,
John Tanner Wilson
Nanoparticle STING Agonist Reprograms the Bone Marrow to an Antitumor Phenotype and Protects Against Bone Destruction.
Cancer research communications
3 (2) (2023)